Soininen Kari, Niemi Mikko, Kilkki Esa, Strandberg Timo, Kivistö Kari T
District Hospital of Kuusankoski, Kuusankoski, Finland.
Basic Clin Pharmacol Toxicol. 2006 Jan;98(1):51-4. doi: 10.1111/j.1742-7843.2006.pto_193.x.
The aim of this study was to examine the clinical profile of statin-induced myalgia in patients with no apparent predisposing factors. Patients who reported muscle complaints that limited daily functioning during statin use were prospectively identified among the patients of Kuusankoski District Hospital and its catchment area, a population of about 100,000, between January 2003 and July 2004. Twenty patients in whom the muscle complaints were probably attributable to the use of a statin were included in this series. There were no cases of severe myopathy or rhabdomyolysis, and the highest creatine kinase value observed was only about 1900 U/l. Of the 18 patients that were evaluable for creatine kinase level, 5 (28%) did not exhibit elevation of creatine kinase and 6 (33%) showed a minor increase only. Following discontinuation of the statin, resolution of symptoms and normalisation of creatine kinase occurred in 11 of the 13 patients with elevated creatine kinase value as well as muscle complaints. Statins may cause clinically important muscle symptoms without inducing a marked creatine kinase elevation.
本研究的目的是调查无明显易感因素的患者中他汀类药物所致肌痛的临床特征。2003年1月至2004年7月期间,在库桑科斯基地区医院及其服务区域(约10万人口)的患者中,前瞻性地识别出那些在使用他汀类药物期间报告有影响日常功能的肌肉不适的患者。本系列纳入了20例肌肉不适可能归因于他汀类药物使用的患者。无严重肌病或横纹肌溶解病例,观察到的最高肌酸激酶值仅约1900 U/l。在可评估肌酸激酶水平的18例患者中,5例(28%)肌酸激酶未升高,6例(33%)仅略有升高。在停用他汀类药物后,13例肌酸激酶值升高且有肌肉不适的患者中有11例症状缓解且肌酸激酶恢复正常。他汀类药物可能导致具有临床意义的肌肉症状,而不引起明显的肌酸激酶升高。